CIK: 0001595851 · Show all filings
Period: Q4 2021 (← Previous) (Next →)
Filing Date: Feb 16, 2022
Total Value: $279M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Share Price | Est. Cost/Share | Unrealized @ Report Date | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|---|
| ASND | ASCENDIS PHARMA A/S | 190,000 | $25.56M | 9.2% | $134.53 | $131.68 | — | SPONSORED ADR | 04351P101 |
| APLS | APELLIS PHARMACEUTICALS INC | 325,000 | $15.37M | 5.5% | $47.28 * | $49.72 | -20.8% | COM | 03753U106 |
| COGT | COGENT BIOSCIENCES INC | 1,700,000 | $14.59M | 5.2% | $8.58 | $10.34 | -15.9% | COM | 19240Q201 |
| CLDX | CELLDEX THERAPEUTICS INC NEW | 350,000 | $13.52M | 4.8% | $38.64 * | $28.96 | +50.5% | COM NEW | 15117B202 |
| — | RAPT THERAPEUTICS INC | 350,000 | $12.86M | 4.6% | $36.73 | $33.20 | — | COM | 75382E109 |
| — | MERUS N V | 350,000 | $11.13M | 4.0% | $31.80 | $29.50 | — | COM | N5749R100 |
| — | IVERIC BIO INC | 625,000 | $10.45M | 3.7% | $16.72 | $7.44 | — | COM | 46583P102 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 500,000 | $9.885M | 3.5% | $19.77 * | $18.53 | +0.5% | COM | 92790C104 |
| IOVA | IOVANCE BIOTHERAPEUTICS INC | 500,000 | $9.545M | 3.4% | $19.09 * | $24.32 | -9.5% | Call | 462260100 |
| RCKT | ROCKET PHARMACEUTICALS INC | 425,000 | $9.278M | 3.3% | $21.83 * | $29.94 | -8.9% | COM | 77313F106 |
| ARVN | ARVINAS INC | 110,000 | $9.035M | 3.2% | $82.14 | $28.07 | +189.9% | COM | 04335A105 |
| SRPT | SAREPTA THERAPEUTICS INC | 100,000 | $9.005M | 3.2% | $90.05 * | $85.49 | 0.0% | COM | 803607100 |
| — | BELLUS HEALTH INC NEW | 891,000 | $7.173M | 2.6% | $8.05 | $6.35 | — | Put | 07987C204 |
| ZNTL | ZENTALIS PHARMACEUTICALS INC | 80,000 | $6.725M | 2.4% | $84.06 * | $61.38 | +26.1% | COM | 98943L107 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 300,000 | $6.567M | 2.4% | $21.89 * | $18.21 | +1.5% | COM | 87164F105 |
| PCVX | VAXCYTE INC | 250,000 | $5.948M | 2.1% | $23.79 * | $21.70 | +7.2% | COM | 92243G108 |
| FOLD | AMICUS THERAPEUTICS INC | 500,000 | $5.775M | 2.1% | $11.55 * | $12.96 | -14.0% | COM | 03152W109 |
| — | SIERRA ONCOLOGY INC | 250,000 | $5.435M | 1.9% | $21.74 | $17.17 | — | COM NEW | 82640U404 |
| ALNY | ALNYLAM PHARMACEUTICALS INC | 30,000 | $5.087M | 1.8% | $169.57 * | $185.86 | 0.0% | COM | 02043Q107 |
| — | VERONA PHARMA PLC | 750,000 | $5.04M | 1.8% | $6.72 | $6.53 | — | SPONSORED ADS | 925050106 |
| WHWK | AADI BIOSCIENCE INC | 200,000 | $4.83M | 1.7% | $24.15 * | $25.11 | 0.0% | COM | 00032Q104 |
| ACRS | ACLARIS THERAPEUTICS INC | 325,000 | $4.726M | 1.7% | $14.54 * | $6.81 | +122.5% | COM | 00461U105 |
| CMPS | COMPASS PATHWAYS PLC | 210,000 | $4.641M | 1.7% | $22.10 | $25.80 | — | SPONSORED ADS | 20451W101 |
| RLMD | RELMADA THERAPEUTICS INC | 200,000 | $4.506M | 1.6% | $22.53 | $26.77 | -16.9% | COM | 75955J402 |
| — | MIRATI THERAPEUTICS INC | 30,000 | $4.401M | 1.6% | $146.70 | $98.34 | — | COM | 60468T105 |
| — | LEAP THERAPEUTICS INC | 1,350,000 | $4.374M | 1.6% | $3.24 | $4.01 | — | COM | 52187K101 |
| — | KEZAR LIFE SCIENCES INC | 250,000 | $4.18M | 1.5% | $16.72 | $16.72 | — | COM | 49372L100 |
| — | SATSUMA PHARMACEUTICALS INC | 904,225 | $4.069M | 1.5% | $4.50 | $10.24 | — | COM | 80405P107 |
| — | VISTAGEN THERAPEUTICS INC | 2,000,000 | $3.9M | 1.4% | $1.95 | $2.02 | — | COM NEW | 92840H202 |
| TARS | TARSUS PHARMACEUTICALS INC | 170,000 | $3.825M | 1.4% | $22.50 * | $31.23 | -16.8% | COM | 87650L103 |
| — | BELLUS HEALTH INC NEW | 450,000 | $3.623M | 1.3% | $8.05 | $6.35 | — | COM NEW | 07987C204 |
| CRNX | CRINETICS PHARMACEUTICALS IN | 118,344 | $3.362M | 1.2% | $28.41 * | $17.57 | +40.3% | COM | 22663K107 |
| PYXS | PYXIS ONCOLOGY INC | 295,000 | $3.236M | 1.2% | $10.97 * | $11.45 | 0.0% | COMMON STOCK | 747324101 |
| — | 9 METERS BIOPHARMA INC | 3,250,000 | $3.181M | 1.1% | $0.98 | $1.25 | — | COM | 654405109 |
| KURA | KURA ONCOLOGY INC | 225,000 | $3.15M | 1.1% | $14.00 * | $28.09 | -42.3% | COM | 50127T109 |
| XENE | XENON PHARMACEUTICALS INC | 100,000 | $3.124M | 1.1% | $31.24 * | $13.60 | +119.7% | COM | 98420N105 |
| — | CTI BIOPHARMA CORP | 1,200,000 | $2.976M | 1.1% | $2.48 | $2.84 | — | COM | 12648L601 |
| DSGN | DESIGN THERAPEUTICS INC | 135,000 | $2.89M | 1.0% | $21.41 * | $17.17 | 0.0% | COM | 25056L103 |
| LRMR | LARIMAR THERAPEUTICS INC | 225,000 | $2.428M | 0.9% | $10.79 * | $11.59 | -4.1% | COM | 517125100 |
| GHRS | GH RESEARCH PLC | 100,000 | $2.333M | 0.8% | $23.33 * | $20.35 | +7.9% | ORDINARY SHARES | G3855L106 |
| — | GLOBAL BLOOD THERAPEUTICS IN | 60,000 | $1.756M | 0.6% | $29.27 | $29.27 | — | COM | 37890U108 |
| IMUX | IMMUNIC INC | 165,000 | $1.579M | 0.6% | $9.57 * | $16.38 | -45.0% | COM | 4525EP101 |
| — | REATA PHARMACEUTICALS INC | 55,000 | $1.45M | 0.5% | $26.36 | $26.36 | — | CL A | 75615P103 |
| ALDX | ALDEYRA THERAPEUTICS INC | 300,000 | $1.2M | 0.4% | $4.00 * | $4.92 | +54.9% | Call | 01438T106 |
| — | PARDES BIOSCIENCES INC | 50,000 | $819K | 0.3% | $16.38 | $16.38 | — | COM | 69945Q105 |
| CABA | CABALETTA BIO INC | 135,000 | $512K | 0.2% | $3.79 * | $9.60 | +11.2% | COM | 12674W109 |